Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel. (Q54023173)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel. |
scientific article |
Statements
Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel. (English)
1 reference
S Sallah
1 reference
G A Gagnon
1 reference
1 January 2000
1 reference
18
1 reference
3
1 reference
191-196
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference